Contract 75N98024A00061
New England Biolabs, Inc. · Department Of Health And Human Services · January 31, 2026
New England Biolabs, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on January 31, 2026 for an undisclosed amount of work in biological product (except diagnostic) manufacturing. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 9, 2026. If all options are exercised, the contract could reach $10.00 million.
Contract details
- PIID
- 75N98024A00061
- Award type
- —
- Pricing
- Firm Fixed Price
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- January 31, 2026
- Latest action
- March 9, 2026
Description
O/M ITEMS ONLY: BIOLOGICAL MATERIALS, CHEMICALS, RNA INTERFERENCE
Modification timeline
-
March 9, 2026Mod P00003 · Other Administrative Action$0
-
January 31, 2026Mod P00002 · Other Administrative Action$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Advanced Technology International | 10 | $225.00M |
| 2 | Sanofi Vaccines Us Inc. | 5 | $27.10M |
| 3 | Meridian Medical Technologies, Llc | 2 | $16.41M |
| 4 | American National Red Cross, The | 12 | $5.59M |
| 5 | Boehringer Ingelheim Animal Health USA Inc | 3 | $3.53M |
| 6 | Versiti Blood Health, Inc. | 12 | $2.52M |
| 7 | American National Red Cross, The | 1 | $1.93M |
| 8 | Miltenyi Biotec, Inc. | 3 | $1.50M |
| 9 | Artemis Technologies Inc | 2 | $983.6K |
| 10 | Oklahoma Blood Institute | 3 | $885.0K |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N98024A00061?
Contract 75N98024A00061 is a federal contract awarded to New England Biolabs, Inc. by Department Of Health And Human Services on January 31, 2026 for an undisclosed amount of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N98024A00061?
New England Biolabs, Inc. won contract 75N98024A00061 from Department Of Health And Human Services.
How much is contract 75N98024A00061 worth?
Contract 75N98024A00061 has obligated $0 to date but carries a potential ceiling of $10.00 million if fully funded and all options are exercised.